Skip to content
Screener

Dividend yield at other companies

Merck & Co. logo
Merck & Co.MRK
2.8%-0.7pp
Amgen logo
AmgenAMGN
2.7%-0.2pp

Other financials

Income statement

See full
Revenue$4.3B+16.7%
Operating income$1.3B+19.8%
Net income$1.3B-6.8%
EPS (diluted)$12.23-4.5%

Balance sheet

See full
Cash & equivalents$2.5B+22.3%
Total debt$2.7B+0.1%
Total equity$31.7B+5.9%
Total assets$41.7B+9.2%

Cash flow

See full
Operating cash flow$813.0M-29.0%
CapEx$240.2M+9.7%
Free cash flow$572.8M-38.1%

Valuation

See full
Market cap$78.52B+29.6%
Enterprise value$78.76B+28.6%
P/E18.1×+4.6×
P/S5.1×+0.8×

Profitability

See full
Gross margin94.9%
Operating margin24.7%-2.3pp
Net margin27.9%-3.5pp
FCF margin24.2%-2.9pp

Returns & leverage

See full
Return on equity14%-1.3pp
Debt / equity0.1×0.0×
Current ratio3.3×-1.3×

Where this comes from

Calculated from Regeneron Pharmaceuticals’s reported figures.

Based on trailing twelve months.

The source filing: Regeneron Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →

Filed
Jul 30, 2026, 6:52 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000872589-26-000025

FAQ

What is Regeneron Pharmaceuticals's dividend yield?
Regeneron Pharmaceuticals (REGN) reported dividend yield of 0.6% in Q2 2026.
How has Regeneron Pharmaceuticals's dividend yield changed year-over-year?
Regeneron Pharmaceuticals's dividend yield increased by 75.1% year-over-year, from 0.3% to 0.6%.
What does dividend yield mean?
Trailing-twelve-month common dividends paid divided by market capitalization at the quarter end. The cash income return shareholders receive relative to the market price.

Ask your AI about Regeneron Pharmaceuticals's dividend yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude